BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20148977)

  • 1. Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A.
    Björkman S
    Haemophilia; 2010 Jul; 16(4):597-605. PubMed ID: 20148977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of recombinant factor IX: implications for dose tailoring.
    Björkman S
    Haemophilia; 2013 Sep; 19(5):753-7. PubMed ID: 23731351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose tailoring of human cell line-derived recombinant factor VIII simoctocog alfa: Using a limited sampling strategy in patients with severe haemophilia A.
    Delavenne X; Dargaud Y; Ollier E; Négrier C
    Br J Clin Pharmacol; 2019 Apr; 85(4):771-781. PubMed ID: 30633808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation.
    Saint-Marcoux F; Debord J; Undre N; Rousseau A; Marquet P
    Ther Drug Monit; 2010 Apr; 32(2):129-35. PubMed ID: 20110850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting.
    Björkman S; Folkesson A; Berntorp E
    Haemophilia; 2007 Jan; 13(1):2-8. PubMed ID: 17212717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring.
    Björkman S; Blanchette VS; Fischer K; Oh M; Spotts G; Schroth P; Fritsch S; Patrone L; Ewenstein BM; ; Collins PW
    J Thromb Haemost; 2010 Apr; 8(4):730-6. PubMed ID: 20398185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia.
    Collins PW; Fischer K; Morfini M; Blanchette VS; Björkman S;
    Haemophilia; 2011 Jan; 17(1):2-10. PubMed ID: 20731726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ReFacto and Advate: a single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia A.
    Di Paola J; Smith MP; Klamroth R; Mannucci PM; Kollmer C; Feingold J; Kessler C; Pollmann H; Morfini M; Udata C; Rothschild C; Hermans C; Janco R
    Haemophilia; 2007 Mar; 13(2):124-30. PubMed ID: 17286764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A.
    Megías-Vericat JE; Bonanad S; Haya S; Cid AR; Marqués MR; Monte E; Pérez-Alenda S; Bosch P; Querol F; Poveda JL
    Thromb Res; 2019 Feb; 174():151-162. PubMed ID: 30634166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
    Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "OPTI-CLOT" trial. A randomised controlled trial on periOperative PharmacokineTIc-guided dosing of CLOTting factor concentrate in haemophilia A.
    Hazendonk HC; van Moort I; Fijnvandraat K; Kruip MJ; Laros-van Gorkom BA; van der Meer FJ; Meijer K; Peters M; Schutgens RE; Zwaan CM; Driessens MH; Polinder S; Leebeek FW; Mathôt RA; Cnossen MH
    Thromb Haemost; 2015 Aug; 114(3):639-44. PubMed ID: 26062822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of pharmacokinetics in the coagulation factor treatment of patients with haemophilia.
    Shapiro AD; Korth-Bradley J; Poon MC
    Haemophilia; 2005 Nov; 11(6):571-82. PubMed ID: 16236106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.
    Deitcher SR; Tuller J; Johnson JA
    Haemophilia; 1999 Mar; 5(2):88-95. PubMed ID: 10215955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited sampling strategies for accurate determination of extended half-life factor VIII pharmacokinetics in severe haemophilia A patients.
    McEneny-King A; Chelle P; Goggans MH; Barker PJ; Jacobs TW; Neufeld EJ; Reiss UM; Panetta JC
    Haemophilia; 2021 May; 27(3):408-416. PubMed ID: 33742733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of blood sampling technique on blood quality and animal welfare in haemophilic mice.
    Holmberg H; Kiersgaard MK; Mikkelsen LF; Tranholm M
    Lab Anim; 2011 Apr; 45(2):114-20. PubMed ID: 21382833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of Web Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo): Patterns of blood sampling and patient characteristics among clinician users.
    McEneny-King A; Yeung CH; Edginton AN; Iorio A; Croteau SE
    Haemophilia; 2020 Jan; 26(1):56-63. PubMed ID: 31742831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?
    Salvagno GL; Astermark J; Lippi G; Ekman M; Franchini M; Guidi GC; Berntorp E
    Haemophilia; 2009 Jan; 15(1):290-6. PubMed ID: 19149855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pharmacokinetics, efficacy and safety of Immunate solvent detergent in previously treated patients with severe haemophilia A.
    Nemes L; Lissitchkov T; Klukowska A; Dobaczewski G; Komrska V; Zimmermann R; Auerswald G; Engl W; Pavlova B; Abbühl B; Ehrlich HJ
    Haemophilia; 2007 Jan; 13(1):9-11. PubMed ID: 17212718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.